Press Release – Adipopharma

press releases

AdipoPharma Recognized at American Diabetes Association 85th Annual Meeting for PATAS, Its First-in-Class Whole-Body Insulin-Sensitizing Compound

June 30, 2025

AdipoPharma obtient un financement pour lancer les essais cliniques de sa molécule, la première de sa catégorie, pour traiter la résistance à l'insuline

November 12, 2024

French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance

November 12, 2024

La biotech alsacienne AdipoPharma et sa molécule miracle à la conquête de l’Amérique

February 9, 2023

AdipoPharma boucle un tour de table pour son médicament contre le diabète

January 24, 2023

French Biotech Company AdipoPharma Secures Series A Funding for Groundbreaking Diabetes Drug

January 23, 2023

La société biotechnologique française AdipoPharma obtient un financement de série A pour un médicament révolutionnaire contre le diabète

January 23, 2023

Series A for AdipoPharma to advance drug for ‘root cause of type 2 diabetes’

January 23, 2023

French biotech company AdipoPharma secures Series A funding for breakthrough diabetes drug

January 23, 2023

AdipoPharma SAS – Headquarters
Nextmed, Bâtiment eXplora (Bureau A203)1907
2 rue Marie Hamm
67000 Strasbourg
France

AdipoPharma SRL
Biopark Gosselies
Belgique

AdipoPharma LLC
US Office Pittsburgh
Pennsylvania, USA

© 2025 AdipoPharma - Privacy Policy | Legal Notice | Management Of The Information Collected